Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma (Q74055987)
scientific article published on 01 August 2000
Language:
(P31) (Q13442814)
(P304) 257-261
(P433) 4
(P478) 64
(P577) Tuesday, August 1, 2000
(P1433) (Q4744246)
(P1476) "Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma" (language: en)
(P2093) T Hara
H Tsurumi
M Takemura
H Goto
T Yamada
M Sawada
T Takahashi
H Moriwaki
other details
description scientific article published on 01 August 2000

External Links